Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 11—November 2019
Dispatch

Orolabial Lymphogranuloma Venereum, Michigan, USA

Sahrish Ilyas, Deborah Richmond, Gerald Burns, Katherine E. Bowden, Kimberly Workowski, Ellen N. Kersh, and Pranatharthi H. ChandrasekarComments to Author 
Author affiliations: Wayne State University School of Medicine, Detroit, Michigan, USA (S. Ilyas, D. Richmond, G. Burns, P.H. Chandrasekar); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (K.E. Bowden, K. Workowski, E.N. Kersh); Emory University, Atlanta (K. Workowski)

Main Article

Table

Reported cases of oropharyngeal LGV worldwide*

Year Country Specimen site Genotype† Prevalence of CT+ oropharyngeal samples Reference
1974 Thailand Oral ulcer LGV Single patient (3)
2011 United Kingdom Throat LGV 1/51 (2%) (4)
2012 Finland Pharynx L2b 1/56 (2%) (5)
2013 United Kingdom Oral ulcer LGV 4/4 (100%) (6)
2015 Netherlands Pharynx LGV 2/23 (8.7%) (7)
2018 France Oropharynx L2, L2b 6/62 (9.7%) (8)
2019 Spain Tongue ulcer LGV Single patient (9)

*CT+, Chlamydia trachomatis–positive; LGV, lymphogranuloma venereum.
†L2 and L2b variant genotypes were determined by sequence variations in ompA (2). LGV genotypes were determined according to the methods described in each study, either anti-LGV complement fixation test or LGV reverse transcription PCR.

Main Article

References
  1. Morré  SA, Spaargaren  J, Fennema  JS, de Vries  HJ. Molecular diagnosis of lymphogranuloma venereum: PCR-based restriction fragment length polymorphism and real-time PCR. J Clin Microbiol. 2005;43:5412Y5413.
  2. Lan  J, Ossewaarde  JM, Walboomers  JM, Meijer  CJ, van den Brule  AJ. Improved PCR sensitivity for direct genotyping of Chlamydia trachomatis serovars by using a nested PCR. J Clin Microbiol. 1994;32:528–30.PubMedGoogle Scholar
  3. Andrada  MT, Dhar  JK, Wilde  H. Oral lymphogranuloma venereum and cervical lymphadenopathy. Case report. Mil Med. 1974;139:99–101. DOIPubMedGoogle Scholar
  4. Elgalib  A, Alexander  S, Tong  CYW, White  JA. Seven days of doxycycline is an effective treatment for asymptomatic rectal Chlamydia trachomatis infection. Int J STD AIDS. 2011;22:474–7. DOIPubMedGoogle Scholar
  5. Korhonen  S, Hiltunen-Back  E, Puolakkainen  M. Genotyping of Chlamydia trachomatis in rectal and pharyngeal specimens: identification of LGV genotypes in Finland. Sex Transm Infect. 2012;88:465–9. DOIPubMedGoogle Scholar
  6. Dosekun  O, Edmonds  S, Stockwell  S, French  P, White  JA. Lymphogranuloma venereum detected from the pharynx in four London men who have sex with men. Int J STD AIDS. 2013;24:495–6. DOIPubMedGoogle Scholar
  7. van Rooijen  MS, van der Loeff  MF, Morré  SA, van Dam  AP, Speksnijder  AG, de Vries  HJ. Spontaneous pharyngeal Chlamydia trachomatis RNA clearance. A cross-sectional study followed by a cohort study of untreated STI clinic patients in Amsterdam, The Netherlands. Sex Transm Infect. 2015;91:157–64. DOIPubMedGoogle Scholar
  8. Desclaux  A, Touati  A, Neau  D, Laurier-Nadalié  C, Bébéar  C, de Barbeyrac  B, et al. Extra-rectal lymphogranuloma venereum in France: a clinical and molecular study. Sex Transm Infect. 2018;94:3–8. DOIPubMedGoogle Scholar
  9. Riera-Monroig  J, Fuertes de Vega  I. Lymphogranuloma venereum presenting as an ulcer on the tongue. Sex Transm Infect. 2019;95:169–70. DOIPubMedGoogle Scholar
  10. de Vries  HJ. The enigma of lymphogranuloma venereum spread in men who have sex with men: does ano-oral transmission plays a role? Sex Transm Dis. 2016;43:420–2. DOIPubMedGoogle Scholar
  11. Kapoor  S. Re-emergence of lymphogranuloma venereum. J Eur Acad Dermatol Venereol. 2008;22:409–16. DOIPubMedGoogle Scholar
  12. de Voux  A, Kent  JB, Macomber  K, Krzanowski  K, Jackson  D, Starr  T, et al. Notes from the Field: Cluster of lymphogranuloma venereum cases among men who have sex with men—Michigan, August 2015–April 2016. MMWR Morb Mortal Wkly Rep. 2016;65:920–1. DOIPubMedGoogle Scholar
  13. Spaargaren  J, Schachter  J, Moncada  J, de Vries  HJ, Fennema  HS, Peña  AS, et al. Slow epidemic of lymphogranuloma venereum L2b strain. Emerg Infect Dis. 2005;11:1787–8. DOIPubMedGoogle Scholar
  14. Olsen  AW, Follmann  F, Erneholm  K, Rosenkrands  I, Andersen  P. Protection against Chlamydia trachomatis infection and upper genital tract pathological changes by vaccine-promoted neutralizing antibodies directed to the VD4 of the major outer membrane protein. J Infect Dis. 2015;212:978–89. DOIPubMedGoogle Scholar
  15. Baehr  W, Zhang  YX, Joseph  T, Su  H, Nano  FE, Everett  KD, et al. Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes. Proc Natl Acad Sci U S A. 1988;85:4000–4. DOIPubMedGoogle Scholar

Main Article

Page created: October 16, 2019
Page updated: October 16, 2019
Page reviewed: October 16, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external